Website News and Research

RSS
Some states see enrollment success even as others, federal insurance exchange struggle

Some states see enrollment success even as others, federal insurance exchange struggle

Viewpoints: Policies being canceled were once considered substandard; that insurance 'was working for people'

Viewpoints: Policies being canceled were once considered substandard; that insurance 'was working for people'

State highlights: Patients crowd free clinic event in Calif.; Mass. bill aims at lowering retiree health costs

State highlights: Patients crowd free clinic event in Calif.; Mass. bill aims at lowering retiree health costs

Health law policy issues: Abortion and maternity coverage raising GOP concerns

Health law policy issues: Abortion and maternity coverage raising GOP concerns

As Healthcare.gov falters, navigators and marketing efforts forced to the sidelines

As Healthcare.gov falters, navigators and marketing efforts forced to the sidelines

Romney says Obama's 'fundamental dishonesty' is undermining second term

Romney says Obama's 'fundamental dishonesty' is undermining second term

A central health law question: Who is getting covered? Who is getting canceled?

A central health law question: Who is getting covered? Who is getting canceled?

Stop L.A. Corruption: A new awareness campaign that highlights failures of LA County

Stop L.A. Corruption: A new awareness campaign that highlights failures of LA County

Most uninsured signing up on health website are going to Medicaid

Most uninsured signing up on health website are going to Medicaid

Details emerge about key fixers in 'tech surge' to address website issues

Details emerge about key fixers in 'tech surge' to address website issues

Democrats feeling health law anxiety over troubled start

Democrats feeling health law anxiety over troubled start

Cardinal Health's non-GAAP operating earnings increase 13% to $532M in Q1 FY 2014

Cardinal Health's non-GAAP operating earnings increase 13% to $532M in Q1 FY 2014

Valeant Pharmaceuticals' total revenues increase 74% to $1.54B in Q3 2013

Valeant Pharmaceuticals' total revenues increase 74% to $1.54B in Q3 2013

Mylan's revenues decrease 2% to $1.77B in third quarter 2013

Mylan's revenues decrease 2% to $1.77B in third quarter 2013

ARIAD temporarily suspends commercial distribution of Iclusig drug in US

ARIAD temporarily suspends commercial distribution of Iclusig drug in US

Viropharma announces financial results for third quarter 2013

Viropharma announces financial results for third quarter 2013

First Edition: October 31, 2013

First Edition: October 31, 2013

Lifestyle Lift, Alliance Data sign multi-year agreement

Lifestyle Lift, Alliance Data sign multi-year agreement

MEDNAX reports revenue growth of 17.3% to $555M

MEDNAX reports revenue growth of 17.3% to $555M

Alkermes reports 38% of year-over-year revenue growth from key products

Alkermes reports 38% of year-over-year revenue growth from key products

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.